TKT and urinary bladder cancer: The data showed that when infected with the recombinant adenovirus RGDAd-UPII-TK in combination with GCV treatment, T24, BIU87 and 5637 cells showed a dramatic decrease in cell viability, whereas the other non-bladder cancer cells showed no obvious cell death.